24-hour Intraocular Pressure and Ocular Perfusion Pressure in Glaucoma

Survey of Ophthalmology

Volumn 58, Issue 1, 2013, Pages 26-41

  Quaranta, Luciano ^a   Katsanos, Andreas ^a,b   Russo, Andrea ^a   Riva, Ivano ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Blood pressure; Circadian rhythm; Glaucoma; Intraocular pressure; Ocular perfusion pressure

Indexed keywords

ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; LATANOPROST; PROSTAGLANDIN; TIMOLOL;

BLOOD PRESSURE; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); DISEASE COURSE; DRUG EFFICACY; EVENING DOSAGE; FILTERING OPERATION; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MONITORING; MORBIDITY; MORNING DOSAGE; OCULAR PERFUSION PRESSURE; OPEN ANGLE GLAUCOMA; PERFUSION PRESSURE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; REVIEW; TELEMETRY; TRABECULECTOMY; TRABECULOPLASTY;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; CIRCADIAN RHYTHM; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; REGIONAL BLOOD FLOW; RETINAL VESSELS;

EID: 84870807297     PISSN: 00396257     EISSN: 18793304     Source Type: Journal    
DOI: 10.1016/j.survophthal.2012.05.003     Document Type: Review

References (127)

1. Agarwal H.C., Sihota R., Das C., et al. Role of argon laser trabeculoplasty as primary and secondary therapy in open angle glaucoma in Indian patients. Br J Ophthalmol 2002, 86:733-736.
2. Alm A., Nilsson S.F.E. Uveoscleral outflow-a review. Exp Eye Res 2009, 88:760-768.
3. Asrani S., Zeimer R., Wilensky J., et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000, 9:134-142.
4. Bafa M., Lambrinakis I., Dayan M., et al. Clinical comparison of the measurement of the IOP with the ocular blood flow tonometer, the Tono-pen XL and the Goldmann applanation tonometer. Acta Ophthalmol Scand 2001, 79:15-18.
5. Bagga H., Liu J.H.K., Weinreb R.N. Intraocular pressure measurements throughout the 24 h. Curr Opin Ophthalmol 2009, 20:79-83.
6. Barkana Y., Anis S., Liebmann J., et al. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol 2006, 124:793-797.
7. Becker B. The decline in aqueous secretion and outflow facility with age. Am J Ophthalmol 1958, 46(5 Part 1):731-736.
8. Bengtsson B., Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol 2005, 243:513-518.
9. Bengtsson B., Leske M.C., Hyman L., et al. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 2007, 114:205-209.
10. Bill A., Hellsing K. Production and drainage of aqueous humour in the cynomolgus monkey (Macaca irus). Invest Ophthalmol Vis Sci 1965, 4:920-926.
11. Bill A., Phillips C.I. Uveoscleral drainage of aqueous humour in human eyes. Exp Eye Res 1971, 12:275-281.
12. Bill A. Physiological aspects of the circulation in the optic nerve. Glaucoma: Conceptions of a Disease 1978, 97-103. Saunders, Philadelphia, WB. K. Heilmann, K.T. Richardson (Eds.).
13. Bonomi L., Marchini G., Marraffa M., et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 2000, 107:1287-1293.
14. Bradley J.M., Vranka J., Colvis C.M., et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci 1998, 39:2649-2658.
15. Brubaker R.F. Flow of aqueous humor in humans [The Friedenwald Lecture]. Invest Ophthalmol Vis Sci 1991, 32:3145-3166.
16. Caprioli J., Coleman A.L. Blood Flow in Glaucoma Discussion. Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol 2010, 149:704-712.
17. Chen C.H., Lu D.W., Chang C.J., et al. The application of water drinking test on the evaluation of trabeculectomy patency. J Ocul Pharmacol Ther 2000, 16:37-42.
18. Choi J., Jeong J., Cho H.-S., Kook M.S. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci 2011, 47:831-836.
19. Choi J., Kim K.H., Jeong J., et al. Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest Ophthalmol Vis Sci 2007, 48:104-111.
20. Costa V.P., Jimenez-Roman J., Carrasco F.G., et al. Twenty-four-hour ocular perfusion pressure in primary open-angle glaucoma. Br J Ophthalmol 2010, 94:1291-1294.
21. Costagliola C., Parmeggiani F., Virgili G., et al. Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 2008, 246:389-396.
22. De Smedt S., Mermoud A., Schnyder C. 24-hour intraocular pressure fluctuation monitoring using an ocular telemetry sensor: tolerability and functionality in healthy subjects. J Glaucoma 2012, 21(8):539-544.
23. Deokule S.P., Doshi A., Vizzeri G., et al. Relationship of the 24-hour pattern of intraocular pressure with optic disc appearance in primary open-angle glaucoma. Ophthalmology 2009, 116:833-839.
24. Drance S.M. Diurnal variation of intraocular pressure in treated glaucoma. Significance in patients with chronic simple glaucoma. Arch Ophthalmol 1963, 70:302-311.
25. Duke-Elder S. The phasic variations in the ocular tension in primary glaucoma. Am J Ophthalmol 1952, 35:1-21.
26. Ellingsen B.A., Grant W.M. Trabeculotomy and sinusotomy in enucleated human eyes. Invest Ophthalmol 1972, 11:21-28.
27. Fagard R.H. Dipping pattern of nocturnal blood pressure in patients with hypertension. Expert Rev Cardiovasc Ther 2009, 7:599-605.
28. Ferrara A.L., Pasanisi F., Crivaro M., et al. Cardiovascular abnormalities in never-treated hypertensives according to nondipper status. Am J Hypertens 1998, 11(11 Pt 1):1352-1357.
29. Flammer J., Orgül S., Costa V.P., et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002, 21:359-393.
30. Gabelt B.T., Kaufman P.L. Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res 2005, 24:612-637.
31. Graham S.L., Drance S.M. Nocturnal hypotension: role in glaucoma progression. Surv Ophthalmol 1999, 43(Suppl 1):S10-S16.
32. Grant W.M. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol 1963, 69:783-801.
33. Grant W.M. Further studies on facility of flow through the trabecular meshwork. AMA Arch Ophthalmol 1958, 60(4 Part 1):523-533.
34. Gulati V., Ghate D.A., Camras C.B., et al. Correlations between parameters of aqueous humor dynamics and the influence of central corneal thickness. Invest Ophthalmol Vis Sci 2011, 52:920-926.
35. Gumus K., Bozkurt B., Sonmez B., et al. Diurnal variation of intraocular pressure and its correlation with retinal nerve fiber analysis in Turkish patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2006, 244:170-176.
36. Hayreh S.S., Podhajsky P., Zimmerman M.B. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica 1999, 213:76-96.
37. Hayreh S.S. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res 2001, 20:595-624.
38. Hoyng P.F., Rulo A., Greve E., et al. The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents. Surv Ophthalmol 1997, 41(Suppl 2):S93-S98.
39. Hughes E., Spry P., Diamond J. 24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma 2003, 12:232-236.
40. Hulsman C.A.A., Vingerling J.R., Hofman A., et al. Blood pressure, arterial stiffness, and open-angle glaucoma: the Rotterdam study. Arch Ophthalmol 2007, 125:805-812.
41. Ishibashi S., Hirose N., Tawara A., et al. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma. J Glaucoma 2006, 15:354-357.
42. Johnson M. What controls aqueous humour outflow resistance?. Exp Eye Res 2006, 82:545-557.
43. Jonas J.B., Budde W.M., Stroux A., et al. Diurnal intraocular pressure profiles and progression of chronic open-angle glaucoma. Eye (Lond) 2007, 21:948-951.
44. Kakaday T., Hewitt A.W., Voelcker N.H., et al. Advances in telemetric continuous intraocular pressure assessment. Br J Ophthalmol 2009, 93:992-996.
45. Kent A.R., Vroman D.T., Thomas T.J., et al. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. J Glaucoma 1999, 8:257-262.
46. Kida T., Liu J.H.K., Weinreb R.N. Effect of 24-hour corneal biomechanical changes on intraocular pressure measurement. Invest Ophthalmol Vis Sci 2006, 47:4422-4426.
47. Kida T., Liu J.H.K., Weinreb R.N. Effect of aging on nocturnal blood flow in the optic nerve head and macula in healthy human eyes. J Glaucoma 2008, 17:366-371.
48. Konstas A.G., Mantziris D.A., Cate E.A., et al. Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma. Arch Ophthalmol 1997, 115:975-979.
49. Konstas A.G.P., Lake S., Economou A.I., et al. 24-hour control with a latanoprost-timolol fixed combination vs timolol alone. Arch Ophthalmol 2006, 124:1553-1557.
50. Konstas A.G.P., Topouzis F., Leliopoulou O., et al. 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma. Ophthalmology 2006, 113:761-765.
51. Konstas A.G.P., Tsironi S., Vakalis A.N., et al. Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma. Acta Ophthalmol 2009, 87:71-76.
52. Kostas A.G., Mantziris D.A., Stewart W.C. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol 1997, 115:182-185.
53. Kóthy P., Tóth M., Holló G. Influence of selective laser trabeculoplasty on 24-hour diurnal intraocular pressure fluctuation in primary open-angle glaucoma: a pilot study. Ophthalmic Surg Lasers Imaging 2010, 41:342-347.
54. Langley D., Swanljung H. Ocular tension in glaucoma simplex. Br J Ophthalmol 1951, 35:445-458.
55. Larsson L.I., Rettig E.S., Brubaker R.F. Aqueous flow in open-angle glaucoma. Arch Ophthalmol 1995, 113:283-286.
56. Lee A.C., Mosaed S., Weinreb R.N., et al. Effect of laser trabeculoplasty on nocturnal intraocular pressure in medically treated glaucoma patients. Ophthalmology 2007, 114:666-670.
57. Lee P.P., Sultan M.B., Grunden J.W., et al. Assessing the importance of IOP variables in glaucoma using a modified delphi process. J Glaucoma 2010, 19:281-287.
58. Lee P.W.-Y., Doyle A., Stewart J.A., et al. Meta-analysis of timolol on diurnal and nighttime intraocular pressure and blood pressure. Eur J Ophthalmol 2010, 20:1035-1041.
59. Lesk M.R., Wajszilber M., Deschenes M.C. The effects of systemic medications on ocular blood flow. Can. J. Ophthalmol 2008, 43:351-355.
60. Leske M.C., Connell A.M., Wu S.Y., et al. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol 1995, 113:918-924.
61. Leske M.C., Heijl A., Hyman L., et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007, 114:1965-1972.
62. Leske M.C., Wu S.-Y., Hennis A., et al. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology 2008, 115:85-93.
63. Liu H., Fan S., Gulati V., et al. Aqueous humor dynamics during the day and night in healthy mature volunteers. Arch Ophthalmol 2011, 129:269-275.
64. Liu J.H., Kripke D.F., Hoffman R.E., et al. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci 1998, 39:2707-2712.
65. Liu J.H.K., Bouligny R.P., Kripke D.F., et al. Nocturnal elevation of intraocular pressure is detectable in the sitting position. Invest Ophthalmol Vis Sci 2003, 44:4439-4442.
66. Liu J.H.K., Gokhale P.A., Loving R.T., et al. Laboratory assessment of diurnal and nocturnal ocular perfusion pressures in humans. J Ocul Pharmacol Ther 2003, 19:291-297.
67. Liu J.H.K., Kripke D.F., Weinreb R.N. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure. Am J Ophthalmol 2004, 138:389-395.
68. Liu J.H.K., Medeiros F.A., Slight J.R., et al. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy. Ophthalmology 2009, 116:449-454.
69. Liu J.H.K., Medeiros F.A., Slight J.R., et al. Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure. Ophthalmology 2010, 117:2075-2079.
70. Liu J.H.K., Zhang X., Kripke D.F., et al. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci 2003, 44:1586-1590.
71. Loewen N.A., Liu J.H.K., Weinreb R.N. Increased 24-hour variation of human intraocular pressure with short axial length. Invest Ophthalmol Vis Sci 2010, 51:933-937.
72. Lütjen-Drecoll E., Shimizu T., Rohrbach M., et al. Quantitative analysis of " plaque material" in the inner and outer wall of Schlemm's canal in normal and glaucomatous eyes. Exp Eye Res 1986, 42:443-455.
73. Lütjen-Drecoll E., Tamm E. Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2 alpha. Exp Eye Res 1988, 47:761-769.
74. Mäepea O., Bill A. Pressures in the juxtacanalicular tissue and Schlemm's canal in monkeys. Exp Eye Res 1992, 54:879-883.
75. Mäepea O. Pressures in the anterior ciliary arteries, choroidal veins and choriocapillaris. Exp Eye Res 1992, 54:731-736.
76. Mansouri K., Medeiros F.A., Weinreb R.N. 24-hour versus daytime intraocular pressure phasing in the management of patients with treated glaucoma [Letter]. Br J Ophthalmol 2011, 95:594-595.
77. Mansouri K., Orguel S., Mermoud A., et al. Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial. Br J Ophthalmol 2008, 92:332-336.
78. Mansouri K., Shaarawy T. Continuous intraocular pressure monitoring with a wireless ocular telemetry sensor: initial clinical experience in patients with open angle glaucoma. Br J Ophthalmol 2011, 95:627-629.
79. Mansouri K., Weinreb R.N., Liu J.H.K. Effects of aging on 24-hour intraocular pressure measurements in sitting and supine body positions. Invest Ophthalmol Vis Sci 2012, 53:112-116.
80. Maus T.L., McLaren J.W., Shepard Jw, et al. The effects of sleep on circulating catecholamines and aqueous flow in human subjects. Exp Eye Res 1996, 62:351-358.
81. Medeiros F.A., Pinheiro A., Moura F.C., et al. Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther 2002, 18:489-498.
82. Millar-Craig M.W., Bishop C.N., Raftery E.B. Circadian variation of blood pressure. Lancet 1978, 1:795-797.
83. Mosaed S., Liu J.H.K., Weinreb R.N. Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients. Am J Ophthalmol 2005, 139:320-324.
84. Muller J.E., Tofler G.H., Stone P.H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989, 79:733-743.
85. Musch D.C., Gillespie B.W., Niziol L.M., et al. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2011, 118:1766-1773.
86. Müskens R.P.H.M., de Voogd S., Wolfs R.C.W., et al. Systemic antihypertensive medication and incident open-angle glaucoma. Ophthalmology 2007, 114:2221-2226.
87. Nakakura S., Nomura Y., Ataka S., et al. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops. J Glaucoma 2007, 16:201-204.
88. Nouri-Mahdavi K., Hoffman D., Coleman A.L., et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004, 111:1627-1635.
89. Ohkubo T., Hozawa A., Yamaguchi J., et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002, 20:2183-2189.
90. Okuno T., Sugiyama T., Kojima S., et al. Diurnal variation in microcirculation of ocular fundus and visual field change in normal-tension glaucoma. Eye (Lond) 2004, 18:697-702.
91. Pikilidou M.I., Tsirou E., Stergiou G.S., et al. Effect of hospitalization on 24-h ambulatory blood pressure of hypertensive patients. Hypertens Res 2010, 33:995-999.
92. Quaranta L., Gandolfo F., Turano R., et al. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma. Invest Ophthalmol Vis Sci 2006, 47:2917-2923.
93. Quaranta L., Konstas A.G.P., Rossetti L., et al. Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry. Eye (Lond) 2010, 24:1252-1258.
94. Quaranta L., Miglior S., Floriani I., et al. Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma. Invest Ophthalmol Vis Sci 2008, 49:4226-4231.
95. Quaranta L., Pizzolante T., Riva I., et al. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma. Br J Ophthalmol 2008, 92:1227-1231.
96. Quigley H.A., West S.K., Rodriguez J., et al. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol 2001, 119:1819-1826.
97. Rasmussen K.E., Jorgensen H.A. Diagnostic value of the water-drinking test in early detection of simple glaucoma. Acta Ophthalmol (Copenh) 1976, 54:160-166.
98. Realini T., Weinreb N., Wisniewski S. Short-term repeatability of diurnal intraocular pressure patterns in glaucomatous individuals. Ophthalmology 2011, 118:47-51.
99. Reiss G.R., Lee D.A., Topper J.E., et al. Aqueous humor flow during sleep. Invest Ophthalmol Vis Sci 1984, 25:776-778.
100. Renard E., Palombi K., Gronfier C., et al. Twenty-four hour (Nyctohemeral) rhythm of intraocular pressure and ocular perfusion pressure in normal-tension glaucoma. Invest Ophthalmol Vis Sci 2010, 51:882-889.
101. Roth J.A. Inadequate diagnostic value of the water-drinking test. Br J Ophthalmol 1974, 58:55-61.
102. Schmidl D., Garhofer G., Schmetterer L. The complex interaction between ocular perfusion pressure and ocular blood flow: relevance for glaucoma. Exp Eye Res 2011, 93:141-155.
103. Sehi M., Flanagan J.G., Zeng L., et al. Relative change in diurnal mean ocular perfusion pressure: a risk factor for the diagnosis of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2005, 46:561-567.
104. Selmaoui B., Touitou Y. Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. Life Sci 2003, 73:3339-3349.
105. Shimada K., Kawamoto A., Matsubayashi K., et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992, 10:875-878.
106. Sit A.J., Asrani S. Effects of medications and surgery on intraocular pressure fluctuation. Surv Ophthalmol 2008, 53(Suppl 1):S45-S55.
107. Staessen J., Bulpitt C.J., O'Brien E., et al. The diurnal blood pressure profile. A population study. Am J Hypertens 1992, 5(6 Pt 1):386-392.
108. Stewart W.C., Konstas A.G.P., Kruft B., et al. Meta-analysis of 24-h intraocular pressure fluctuation studies and the efficacy of glaucoma medicines. J Ocul Pharmacol Ther 2010, 26:175-180.
109. Stewart W.C., Konstas A.G.P., Nelson L.A., et al. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Ophthalmology 2008, 115:1117-1122.
110. Sultan M., Blondeau P. Episcleral venous pressure in younger and older subjects in the sitting and supine positions. J Glaucoma 2003, 12:370-373.
111. Sung K.R., Lee S., Park S.B., et al. Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression. Invest Ophthalmol Vis Sci 2009, 50:5266-5274.
112. Sung K.R., Cho J.W., Lee S., et al. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure. Invest Ophthalmol Vis Sci 2011, 52:737-743.
113. Takeda N., Maemura K. Circadian clock and vascular disease. Hypertens Res 2010, 33:645-651.
114. Tamm E.R., Fuchshofer R. What increases outflow resistance in primary open-angle glaucoma?. Surv Ophthalmol 2007, 52(Suppl 2):S101-S104.
115. Tamm S., Tamm E., Rohen J.W. Age-related changes of the human ciliary muscle. A quantitative morphometric study. Mech Ageing Dev 1992, 62:209-221.
116. Tielsch J.M., Katz J., Sommer A., et al. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995, 113:216-221.
117. Tokunaga T., Kashiwagi K., Tsumura T., et al. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol 2004, 48:380-385.
118. Topouzis F., Coleman A.L., Harris A., et al. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: the Thessaloniki eye study. Am J Ophthalmol 2006, 142:60-67.
119. Topper J.E., Brubaker R.F. Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep. Invest Ophthalmol Vis Sci 1985, 26:1315-1319.
120. Toris C.B., Koepsell S.A., Yablonski M.E., et al. Aqueous humor dynamics in ocular hypertensive patients. J Glaucoma 2002, 11:253-258.
121. Toris C.B., Yablonski M.E., Wang Y.L., et al. Aqueous humor dynamics in the aging human eye. Am J Ophthalmol 1999, 127:407-412.
122. Toris C.B., Zhan G.L., Zhao J., et al. Potential mechanism for the additivity of pilocarpine and latanoprost. Am J Ophthalmol 2001, 131:722-728.
123. Verdecchia P., Schillaci G., Guerrieri M., et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990, 81:528-536.
124. Weinreb R.N., Kashiwagi K., Kashiwagi F., et al. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci 1997, 38:2772-2780.
125. Xu L., Wang Y.X., Jonas J.B. Ocular perfusion pressure and glaucoma: the Beijing Eye Study. Eye (Lond) 2009, 23:734-736.
126. Yoshikawa K., Inoue T., Inoue Y. Normal tension glaucoma: the value of predictive tests. Acta Ophthalmol (Copenh) 1993, 71:463-470.
127. Zheng Y., Wong T.Y., Mitchell P., et al. Distribution of ocular perfusion pressure and its relationship with open-angle glaucoma: the singapore malay eye study. Invest Ophthalmol Vis Sci 2010, 51:3399-3404.